Qilu Network Lightning News August 1, 2021, the 2021 China Hospital High-quality Development Summit Forum was held in Jinan, dozens of well-known hospitals, pharmaceutical companies, experts and scholars from dozens of well-known hospitals, pharmaceutical companies and government health department leaders gathered together to jointly seek a high-quality development plan for the hospital.
Li Yan, President of Qilu Pharmaceutical Group, was invited to deliver a keynote speech entitled "Adhere to Innovation and Leadership, Work Together to Help the High-quality Development of Hospitals".
Li Yan said that since the Eighteenth National Congress of the Communist Party of China, China has deeply implemented the Healthy China Strategy. As an important implementer of the Healthy China Strategy, the medical and pharmaceutical industry is an actor and strivers who seek health for patients and happiness for the people. She used the four "highly consistent" of "original intention, mission, task, and emotion" of medicine and medicine to vividly explain the concept that medicine and medical treatment are high-quality development communities that undertake the people's health cause.
The healer is benevolent, and the medicineman is wise. Li Yan believes that in the face of the new requirements and new challenges put forward by the development of the times and social progress on the high-quality development of medical and health undertakings, "medical and medical and health workers are like comrades in the same trench", taking the satisfaction of the people's demand for higher level medical care as the unswerving goal of struggle, and the fate and common destiny and breathing together.
Li Yan said that high-quality development is a common issue of the times faced by hospitals, pharmaceutical industries and enterprises, and the two sides need to adhere to the "four aspects" of scientific and technological innovation, further seek development in cooperation, innovate side by side, seek health for patients, seek happiness for the people, and move forward in a win-win situation.
She made two suggestions. First, it is necessary to deepen clinical research cooperation. Working together to build an international standard clinical medical transformation platform, the hospital puts forward the needs of new drugs, new dosage forms and new indications, brings together the scientific research advantages and resource elements of both sides, and promotes the industrialization of pharmaceutical enterprises. In particular, we will work together in cutting-edge technologies such as immunotherapy, cell therapy, and gene therapy to open up the chain of innovation, production, and use. Jointly explore new therapies and new models to develop innovative drugs, with the purpose of improving clinical patient compliance and treatment effects, and jointly develop new drug therapies for new drug administration, new combinations, and new dosage forms. Especially in the field of tumor treatment, in-depth cooperation is carried out in new drug trials, post-marketing exploration research, and clinical and translational medicine.
The second is to explore new models of cooperation with the help of new technologies and applications of the Internet. Li Yan said that the new generation of information technology such as cloud computing, big data, and 5G is deeply integrated with medical services and drug research and development, and will gradually open up data faults such as pharmaceutical research and development, production, circulation, use and comprehensive services, and the application scenarios in clinical scientific research, drug clinical trials, drug marketing evaluation, real-world research and other aspects will become clearer and more perfect. In these areas, the two sides should establish a standardized and standardized clinical big data system, support China's pharmaceutical companies to make rational use in an appropriate way, conduct efficient research on multiple and refractory clinical diseases, give full play to the role of the Internet in the era of medical and health big data, and promote China's medical and health undertakings to enter the era of informatization and intelligence.
Lightning News reporter Zhou Yingchun reported